Company intelligence / Profile preview
Scharper S.p.A.
- Ownership
- Private
- Development stage
- Commercial
Overview
Scharper S.p.A. develops dietary supplements and markets pharmaceutical products with a scientific approach. The company emphasizes eco-sustainability and applies rigorous standards to both drug and non-drug products. It has an established presence in Italy with a focus on improving quality of life through its offerings in ENT, respiratory, cardiovascular, and pediatric segments.
- Therapeutic areas
- OtherPulmonologyCardiovascular
- Modalities
- Dietary supplementspharmaceuticals (likely small molecules and natural products)
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Scharper S.p.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scharper S.p.A..